Market Challenges And Opportunities
- Risk of needlestick injuries
- Low penetration in underdeveloped regions
- Presence of alternative modes of blood collection
Global Butterfly Needles Market Drivers
- Increasing prevalence of chronic diseases driving demand for butterfly needles: Rising prevalence of chronic diseases such as diabetes, cancer, and kidney disorders is increasing the demand for regular diagnosis tests and treatments, which is driving the growth of the butterfly needles market. In 2020, according to the World Health Organizations (WHO), chronic diseases accounted for 60% of all deaths worldwide.
- Growing demand for blood transfusions and blood donations: Increasing number of surgical procedures, road accidents, traumas, and anemia cases is escalating the demand for blood transfusions. This is fueling the adoption of butterfly needles for efficient blood sample collection. In 2021, according to the report by World Health Organizations (WHO), 118.5 Mn blood donations are collected globally every year.
- Rise in hospitalization rates and need for effective venipuncture: Rising hospitalization rates due to the increasing burden of chronic diseases is leading to high demand for intravenous needles and infusion pumps. Butterfly needles enable easy and painless venipuncture as compared to traditional needles.
- Technological advancements in butterfly needle designs: Key manufacturers are focusing on developing advanced butterfly needle designs such as safety butterfly needles with sharps injury prevention features. The launch of ergonomic needle designs is gaining traction among healthcare providers.
Global Butterfly Needles Market Opportunities
- Increasing demand from emerging countries: The improving healthcare infrastructure and rising healthcare expenditure in emerging economies such as China, India, Brazil, and Southeast Asia is creating lucrative growth opportunities for butterfly needle manufacturers. The expanding patient pool in these countries is driving the product demand for butterfly needles.
- Rising adoption of safety needle devices: The growing awareness of needlestick injuries is fueling the adoption of safety butterfly needle devices for integrated sharps injury prevention features. Key players are focusing on new product launches to capitalize on this opportunity. Moreover, The Centers for Disease Control and Prevention (CDC), 2020, estimates that each year 385,000 needlestick injuries (NSIs) and other sharps-related injuries are sustained by hospital-based healthcare personnel.
- Technological advancements in needle size variants: The introduction of smaller, non-coring butterfly needles which are designed for pediatric and geriatric patients is expected to create new revenue opportunities due to the rising geriatric population and pediatric healthcare needs.
- Growing use in home healthcare setting: Increasing use of butterfly needles for home infusion and dialysis therapies is expected to widen the consumer base for manufacturers. Expanding home healthcare services is leading to new product adoption avenues.
Global Butterfly Needles Market Restrains
- Risk of needlestick injuries: Conventional butterfly needles pose the risk of needlestick injuries which can cause blood-borne pathogen transmission between patients and healthcare workers. This is negatively impacting adoption among healthcare facilities.
- Low penetration in underdeveloped regions: The lack of advanced healthcare infrastructure, limited patient awareness, and lower healthcare budgets are hampering butterfly needle adoption in underdeveloped regions and rural areas of emerging economies.
Presence of alternative modes of blood collection
- The availability of alternative blood collection methods like vacuum tubes, syringes, capillary tubes is limiting the universal adoption of butterfly needle devices across all patient demographics.
- Counterbalance: The use of conventional butterfly needles should be proper so that no pathogen transmission takes place among the healthcare workers. Proper awareness program needs to be carried out in the underdeveloped regions so that it can easily adopt in those areas. Options for alternative modes of blood collection should also be universally available.